LNWWM
DXCM icon

Laird Norton Wetherby Wealth Management’s DexCom DXCM Stock Holding History

Laird Norton Wetherby Wealth Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$556K Buy
8,260
+905
+12% +$71.6K 0.02% 544
2025
Q2 		$642K Buy
+7,355
New +$577K 0.03% 488
2024
Q4 		$580K Buy
7,456
+1,040
+16% +$77K 0.03% 482
2024
Q3 		$430K Sell
6,416
-3,184
-33% -$261K 0.02% 615
2024
Q2 		$1.09M Sell
9,600
-891
-8% -$113K 0.05% 330
2024
Q1 		$1.46M Sell
10,491
-62
-0.6% -$7.79K 0.07% 276
2023
Q4 		$1.31M Buy
10,553
+646
+7% +$66K 0.07% 287
2023
Q3 		$924K Sell
9,907
-530
-5% -$59.7K 0.05% 343
2023
Q2 		$1.34M Sell
10,437
-86
-0.8% -$10.4K 0.07% 278
2023
Q1 		$1.22M Buy
10,523
+56
+0.5% +$6.27K 0.07% 286
2022
Q4 		$1.19M Buy
10,467
+604
+6% +$66.3K 0.08% 289
2022
Q3 		$794K Buy
9,863
+1,621
+20% +$137K 0.06% 340
2022
Q2 		$614K Sell
8,242
-2,762
-25% -$252K 0.04% 429
2022
Q1 		$1.41M Buy
11,004
+292
+3% +$31.9K 0.08% 235
2021
Q4 		$1.44M Buy
10,712
+148
+1% +$21.3K 0.08% 229
2021
Q3 		$1.44M Buy
10,564
+332
+3% +$41.9K 0.09% 212
2021
Q2 		$1.09M Buy
10,232
+4,192
+69% +$403K 0.07% 272
2021
Q1 		$543K Sell
6,040
-4,564
-43% -$428K 0.04% 410
2020
Q4 		$980K Buy
10,604
+3,720
+54% +$332K 0.07% 276
2020
Q3 		$710K Sell
6,884
-36
-0.5% -$3.76K 0.06% 297
2020
Q2 		$701K Buy
6,920
+1,128
+19% +$101K 0.07% 286
2020
Q1 		$390K Buy
5,792
+1,548
+36% +$96.3K 0.04% 385
2019
Q4 		$232K Buy
+4,244
New +$201K 0.02% 618

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Laird Norton Wetherby Wealth Management's DXCM Position: Q3 2025 in Review

Laird Norton Wetherby Wealth Management increased its DexCom (DXCM) stake by 12% in Q3 2025, buying an estimated $71.6K and bringing the position to 8,260 shares worth $556K. The position accounts for 0.02% of the portfolio, ranked #544.

Laird Norton Wetherby Wealth Management first reported a position in DXCM in Q4 2019 and has held it in 23 quarters since. The position peaked at $1.46M in Q1 2024. 910 funds tracked by Wall St. Rank hold DXCM as of Q3 2025.

  • Laird Norton Wetherby Wealth Management held 8,260 shares of DexCom worth $556K as of Q3 2025.
  • Laird Norton Wetherby Wealth Management bought 905 DexCom shares in Q3 2025, an estimated $71.6K.
  • DexCom made up 0.02% of Laird Norton Wetherby Wealth Management's portfolio in Q3 2025, its #544 holding.
  • Laird Norton Wetherby Wealth Management first reported a position in DexCom in Q4 2019 and has held it in 23 quarters since.
  • Laird Norton Wetherby Wealth Management's DexCom position peaked at $1.46M in Q1 2024.
  • 910 funds tracked by Wall St. Rank held DexCom as of Q3 2025.

Based on Laird Norton Wetherby Wealth Management's 13F filing for Q3 2025, filed 14 Nov 2025.